BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26487234)

  • 21. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma.
    Wakelin SJ; Deans C; Crofts TJ; Allan PL; Plevris JN; Paterson-Brown S
    Eur J Radiol; 2002 Feb; 41(2):161-7. PubMed ID: 11809546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of FDG-PET in the preoperative staging of esophageal cancer.
    Gananadha S; Hazebroek EJ; Leibman S; Berry H; Osgood L; Shon IH; Pavlakis N; Marx G; Smith GS
    Dis Esophagus; 2008; 21(5):389-94. PubMed ID: 19125791
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Schneider PM; Eshmuminov D; Rordorf T; Vetter D; Veit-Haibach P; Weber A; Bauerfeind P; Samaras P; Lehmann K
    BMC Cancer; 2018 May; 18(1):548. PubMed ID: 29743108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
    Mochiki E; Kuwano H; Katoh H; Asao T; Oriuchi N; Endo K
    World J Surg; 2004 Mar; 28(3):247-53. PubMed ID: 14961197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
    Bjerring OS; Hess S; Petersen H; Fristrup CW; Lundell L; Mortensen MB
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33688946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
    Altini C; Niccoli Asabella A; Di Palo A; Fanelli M; Ferrari C; Moschetta M; Rubini G
    Medicine (Baltimore); 2015 May; 94(20):e864. PubMed ID: 25997066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands.
    Gertsen EC; Borggreve AS; Brenkman HJF; Verhoeven RHA; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP;
    Ann Surg Oncol; 2021 Apr; 28(4):2384-2393. PubMed ID: 32901312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of
    de Jongh C; van der Meulen MP; Gertsen EC; Brenkman HJF; van Sandick JW; van Berge Henegouwen MI; Gisbertz SS; Luyer MDP; Nieuwenhuijzen GAP; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; de Steur WO; Hartgrink HH; Stoot JHMB; Hulsewe KWE; Spillenaar Bilgen EJ; van Det MJ; Kouwenhoven EA; Daams F; van der Peet DL; van Grieken NCT; Heisterkamp J; van Etten B; van den Berg JW; Pierie JP; Eker HH; Thijssen AY; Belt EJT; van Duijvendijk P; Wassenaar E; Wevers KP; Hol L; Wessels FJ; Haj Mohammad N; Frederix GWJ; van Hillegersberg R; Siersema PD; Vegt E; Ruurda JP;
    Ann Surg Oncol; 2024 Jun; 31(6):4005-4017. PubMed ID: 38526832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 5-point 18-FDG-PET/CT visual scoring system for assessing treatment response in patients with oesophageal or gastro-oesophageal junction carcinoma.
    Cong E; Oar AJ; Lee MT; Chicco A; Lin M; Yap J; Lin P; Ho Shon I
    J Med Imaging Radiat Oncol; 2021 Feb; 65(1):23-37. PubMed ID: 33063470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
    Alberini JL; Lerebours F; Wartski M; Fourme E; Le Stanc E; Gontier E; Madar O; Cherel P; Pecking AP
    Cancer; 2009 Nov; 115(21):5038-47. PubMed ID: 19645022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy.
    Kole AC; Plukker JT; Nieweg OE; Vaalburg W
    Br J Cancer; 1998 Aug; 78(4):521-7. PubMed ID: 9716038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
    Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
    Lee DH; Kim SH; Joo I; Hur BY; Han JK
    Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
    Fencl P; Belohlavek O; Harustiak T; Zemanova M
    Abdom Radiol (NY); 2016 Nov; 41(11):2089-2094. PubMed ID: 27405645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.
    Namikawa T; Okabayshi T; Nogami M; Ogawa Y; Kobayashi M; Hanazaki K
    Int J Clin Oncol; 2014 Aug; 19(4):649-55. PubMed ID: 23877653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.